
Schering-Plough Corporation
Schering-Plough Corporation (NYSE: SGP) has announced a license agreement between Nobilon, Schering-Plough's human vaccine business unit, and the World Health Organization (WHO) to provide access to pandemic influenza vaccine manufacturing technology to developing countries. Fred Hassan, chairman and CEO, said, "This project demonstrates Schering-Plough's strong commitment to innovation and to providing access to medicines. The avian influenza virus is already affecting several developing countries, making pandemic influenza vaccine preparedness a global health priority.